FALSE000111192800011119282024-02-162024-02-16

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K
CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

February 16, 2024
 Date of Report (Date of earliest event reported)

IPG PHOTONICS CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
 (State or Other Jurisdiction
 of Incorporation)
 
 
001-33155
 (Commission File No.)
04-3444218
 (IRS Employer
 Identification No.)
377 Simarano Drive
Marlborough, Massachusetts 01752
(Address of Principal Executive Offices, including Zip Code)

(508373-1100
(Registrant’s telephone number)

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, par value $0.0001 per shareIPGPNasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company  
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 



Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Principal Officers.

(e) Executive Compensation

The Compensation Committee (the “Committee”) of the Board of Directors (the “Board”) of the Company and the Board took the actions described below relating to the compensation of the Company's named executive officers (as set forth in the Company's most recent proxy statement filed with the Securities and Exchange Commission) and certain other executive officers of the Company.

The Board recently approved the base salary, performance measures and target incentive payouts for 2024 as well as long term equity incentives for the CEO. The Committee approved the same for other executive officers of the Company. Base salaries for Dr. Scherbakov and Messrs. Mammen and Lopresti did not change from 2023 levels. Base salaries for Dr. Ovtchinnikov and Mr. Ness increased 5% from 2023 levels. The 2024 base salaries of the named executive officers are presented below:

NameBase Salary 2023Base Salary 2024
Eugene Scherbakov, Ph.D.€800,000€800,000
Timothy P.V. Mammen$538,700$538,700
Angelo P. Lopresti$485,500$485,500
Trevor Ness$477,100$501,000
Alexander Ovtchinnikov, Ph.D.$481,000$505,100
    

The approved annual targets and incentive payouts for the Company's named executive officers and other executive officers are governed by the Company’s Senior Executive Annual Incentive Plan for fiscal year 2024 (the “AIP”). Consistent with prior years, the Committee identified two financial performance measures: net sales and adjusted EBIT (excluding equity-based compensation expenses, foreign currency transaction gains and losses and certain charges and write-downs), each as determined under the AIP, and assigned a 50% weighting factor to each financial performance goal.

Under the 2024 AIP, the executive officers can receive cash incentive payments listed in the following table as a percentage of base salaries based upon achievement of the minimum to maximum objectives for both financial performance measures and for individual performance. Target bonuses as a percentage of salary remain the same as 2023 levels for the named executive officers.

Name
Target (Financial plus Individual)(1)
Financial Performance Minimum(1)
Financial Performance Maximum(1)
Individual Performance Maximum(1)
Maximum Award Payout(1)(2)
Eugene Scherbakov, Ph.D.110%41.25%220%27.50%247.50%
Timothy P.V. Mammen
80%
30%
160%
20%
180%
Angelo P. Lopresti
80%
30%
160%
20%
180%
Trevor Ness80%30%160%20%180%
Alexander Ovtchinnikov, Ph.D.80%30%160%20%180%
(1)As a percentage of base salary.
(2)Maximum award payout is 225% of the target award (financial plus individual).
The Committee may make adjustments under the AIP, including to our overall corporate performance goals, and the ways that our actual performance results are calculated that may cause differences between the numbers used for our performance goals and the numbers reported in our financial statements.

The Committee also approved grants of long-term incentives in the form of equity awards. The 2024 equity-based awards consist of service-based restricted stock units (“RSUs”) weighted 50% and performance-based stock units (“PSUs”)



weighted 50%. The RSUs vest annually over three years on March 1, 2025, 2026 and 2027. To the extent earned, the PSUs vest March 1, 2027.

The Committee decided to weight the PSUs 50% on revenue and 50% on operating margin. PSUs based upon revenue well be eligible to be earned over three one-year performance periods starting on January 1, 2024. The PSUs based upon operating margin will be eligible to be earned based upon the Company's average annual operating margin measured over the same performance periods. The PSUs specify a target, threshold and maximum for each performance metric. In order to provide additional incentive, to further align the interests of the named executive officers with our stockholders and to motivate the named executive officers to drive continued future performance in 2024 and beyond, the Committee approved a one-time, additional LTI target value opportunity in 2024 for the named executive officers other than the CEO. The additional target value opportunities for these named executive officers represent 40% of the regular annual LTI award.

The following table lists the RSUs and PSUs awarded to the named executive officers:

Name
Service-Based Restricted Stock
Performance Stock Units
on Organic Revenue CAGR
Performance Stock Units
on Operating Margin
Eugene Scherbakov, Ph.D.28,87714,43814,438
Timothy P.V. Mammen13,0806,5406,540
Angelo P. Lopresti10,8065,4035,403
Trevor Ness11,1505,5755,575
Alexander Ovtchinnikov, Ph.D.11,2425,6215,621







SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned thereunto duly authorized.
 
IPG PHOTONICS CORPORATION
February 21, 2024By:/s/ Angelo P. Lopresti
Angelo P. Lopresti
Senior Vice President, General Counsel & Secretary


v3.24.0.1
Document and Entity Information
Feb. 16, 2024
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001111928
Document Type 8-K
Document Period End Date Feb. 16, 2024
Entity Registrant Name IPG PHOTONICS CORP
Entity Incorporation, State or Country Code DE
Entity File Number 001-33155
Entity Tax Identification Number 04-3444218
Entity Address, Address Line One 377 Simarano Drive
Entity Address, City or Town Marlborough
Entity Address, State or Province MA
Entity Address, Postal Zip Code 01752
City Area Code 508
Local Phone Number 373-1100
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol IPGP
Security Exchange Name NASDAQ
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false

IPG Photonics (NASDAQ:IPGP)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more IPG Photonics Charts.
IPG Photonics (NASDAQ:IPGP)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more IPG Photonics Charts.